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Several studies have re p o rted that up to50% of all subjects with diabetes areundiagnosed (1–4). Although these
subjects are not aware of their disease, they
a re at risk for the micro- and macro v a s c u-
lar complications of diabetes (5,6). Early
t reatment of diabetes and the associated
c a rdiovascular risk factors (hypert e n s i o n ,
o b e s i t y, dyslipidemia) may reduce the
o c c u rrence of these complications (7).
T h e re f o re, early detection of subjects with
undiagnosed diabetes might be of impor-
tance in reducing the burden of complica-
tions of diabetes. Identifying people at
i n c reased risk for undiagnosed diabetes,
followed by blood glucose testing to estab-
lish diagnosis, is considered to be an appro-
priate way of dealing with this problem (8).
The American Diabetes Association (ADA)
recommends screening for type 2 diabetes
by using a verbal or written questionnaire
to select high-risk individuals to incre a s e
the cost-effectiveness of testing undiag-
nosed individuals (9).
A number of questionnaires have been
developed to identify subjects with an
i n c reased risk of undiagnosed diabetes
(10–12). However, a tool based on infor-
mation already available to a general prac-
titioner would be more easily implemented
in the current health care setting. In a sam-
ple of the Rotterdam Study in the Nether-
lands, we developed a predictive model to
identify individuals at increased risk for
undiagnosed diabetes, using inform a t i o n
routinely collected by the general practi-
t i o n e r. In addition, we developed pre d i c t i v e
models using information collected by sim-
ple questions or physical examination.
These predictive models were tested in the
H o o rn Study, another Dutch population-
based study (3), and their diagnostic value
is evaluated in this study.
RESEARCH DESIGN AND
M E T H O D S
Rotterdam Study
The present study was conducted among
p a rticipants of the Rotterdam Study (13).
The selection of the study sample is
described in detail elsewhere (14). A base-
line examination was conducted from 1990
to 1993 and included 7,983 subjects aged
55 years (response rate 78%). Based on
the baseline nonfasting oral glucose toler-
ance test (OGTT), participants aged 55–75
years were temporarily classified as diabetic
(using medication or random or postload
level 11.1 mmol/l), hyperinsulinemic
(upper quintile of the gender- s p e c i fic post-
load insulin distribution in subjects without
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P e rf o rmance of a Predictive Model to
Identify Undiagnosed Diabetes in a
Health Care Setting
O R I G I N A L  A R T I C L E
O B J E C T I V E — To develop a predictive model to identify individuals with an increased risk for
undiagnosed diabetes, allowing for the availability of information within the health care system.
RESEARCH DESIGN AND METHODS — A sample of participants from the Rotter-
dam Study (n = 1,016), aged 55–75 years, not known to have diabetes completed a question-
n a i re on diabetes-related symptoms and risk factors and underwent a glucose tolerance test.
P redictive models were developed using stepwise logistic re g ression analyses with the absence
or presence of newly diagnosed diabetes as the dependent variable and various items with a
plausible connection to diabetes as the independent variables. The models were evaluated in
another Dutch population-based study, the Hoorn Study (n = 2,364), in which the part i c i p a n t s
w e re aged 50–74 years. Perf o rmances of the predictive models were compared by using
re c e i v e r-operator characteristics (ROC) curv e s .
R E S U LT S — We developed three predictive models (PMs). PM1 contained information ro u-
tinely collected by the general practitioner, while PM2 also contained variables obtainable by
additional questions. The third predictive model, PM3, included variables that had to be
obtained from a physical examination. These latter variables did not have additive pre d i c t i v e
value, resulting in a PM3 similar to PM2. The area under the ROC curve was higher for PM2
than for PM1, but the 95% CIs overlapped (0.74 [0.70–0.78] and 0.68 [0.64–0.72], re s p e c t i v e l y ) .
C O N C L U S I O N S — Using only information normally present in the files of a general prac-
t i t i o n e r, a predictive model was developed that perf o rmed similarly to one supplemented by
i n f o rmation obtained from additional questions. The simplicity of PM1 makes it easy to imple-
ment in the current health care setting.
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i m p a i red glucose tolerance [IGT] or dia-
betes) or normal glucose tolerant. A strati-
fied random sample was taken from each
g roup to participate in the Rotterdam Dia-
betes Study. The overall response rate in the
follow-up examination was 90%, and 1,112
subjects took part in the diabetes study. In
this study, a definitive classification of the
glucose tolerance status was made, based on
a fasting OGTT.
The participants came to the re s e a rc h
center after an overnight fast (no food
intake after 11:00 P.M.), and had blood
taken between 8:00 and 9:00 A.M. S u b j e c t s
not using antidiabetic medication went on
to have a standard 75-g OGTT (15). Fast-
ing and 2-h plasma glucose levels were
d e t e rmined using the glucose hexokinase
method. Diabetes was defined as the use of
antidiabetic medication (insulin or oral
hypoglycemic medication) and/or a 2-h
plasma glucose concentration 1 1 . 1
mmol/l according to World Health Org a n-
ization (WHO) criteria (15). Subjects with
a glucose level in the diabetic range who
did not use antidiabetic medication were
c l a s s i fied as newly diagnosed cases of dia-
betes. All known diabetic patients (n = 69)
w e re excluded from the present analysis.
I n f o rmation on medication use, medical
h i s t o ry (cardiovascular disease, stro k e ) ,
smoking habits, and family history (fir s t
d e g ree) of diabetes was obtained from a self-
a d m i n i s t e red questionnaire. The Rose ques-
t i o n n a i re was used to assess angina pectoris
and intermittent claudication (16). Physical
activity was assessed by a self-administere d
q u e s t i o n n a i re derived from one originally
designed for re t i red men and described by
Caspersen et al. (17). This was modified for
use in the current study by the addition of
questions of household activities (14).
Sitting blood pre s s u re was measure d
with a random-zero sphygmomanometer,
and the mean of two measurements was
used in the analyses. Weight and height
w e re measured with the participants wear-
ing indoor clothes and no shoes. Waist cir-
c u m f e rence was measured midway between
the lower rib margin and iliac crest; hip cir-
c u m f e rence was measured at the tro c h a n t e r
m a j o r. BMI was determined by dividing the
weight by the height squared (kilograms per
meter squared) and body fat distribution
was assessed by means of the waist-to-hip
c i rc u m f e rence ratio (WHR).
Analysis
We used three levels of information, defin e d
by the degree of eff o rt needed by a general
practitioner for their collection. Level 1 is
n o rmally present in routine general practi-
tioner re c o rds, level 2 is obtainable by sim-
ple questions, and level 3 re q u i res additional
m e a s u rements. Three predictive models
w e re developed, based on these three levels
of information. In Table 1, the variables
used for analysis are grouped according to
the level of inform a t i o n .
Within each level of information, a step-
wise logistic re g ression analysis was used
with the absence or presence of newly
detected diabetes as the dependent variable
and the variables of the predictive model as
independent variables. Any symptom or risk
factor associated with newly detected dia-
betes at a significance level of P 0.05 was
included in the first predictive model. This
model was extended to include the variables
of the second model and, subsequently, those
of the third model as well. The re g re s s i o n
c o e fficients of the predictive models were
t r a n s f o rmed into scores (multiplied by 10
and rounded off to the nearest integer) that
w e re added up to obtain an aggregated score .
All analyses were perf o rmed with the SPSS-
PC software package, version 7.0.
Validation of the predictive models
The derived predictive models were tested
in the Hoorn Study. A random sample of
50- to 74-year-old subjects was taken fro m
the population register of the town of
H o o rn in the Netherlands. The final Hoorn
c o h o rt consisted of 2,484 subjects, as
described previously (3). All subjects who
re p o rted having diabetes (n = 104) were
excluded from the present analysis. Part i c-
ipants completed a detailed questionnaire
on symptoms and risk factors for diabetes
b e f o re visiting the center. All part i c i p a n t s
u n d e rwent a 75-g OGTT and were classi-
fied according to WHO criteria (15).
Height and weight of the subjects were also
m e a s u red without shoes and outer gar-
ments during the visit.
Table 1—Characteristics of the Rotterdam Diabetes Study population ordered by level of
information
Newly detected
Variables Nondiabetic diabetes OR (95% CI)
n 898 118 —
Level 1: present in routine general
practice records
Age (years) 66.2 ± 5.5 67.8 ± 5.7 —
Sex (% F) 51.7 41.5 —
Presence of obesity 13.2 20.3 1.75 (1.07–2.88)
Use of antihypertensive medication 24.6 35.6 1.57 (1.04–2.38)
Use of lipid-lowering medication 5.3 6.8 1.29 (0.59–2.82)
Gestational diabetes (% of the women) 1 0 —
Prevalence of cardiovascular disease 13.7 22.0 1.54 (0.95–2.51)
Level 2: additional questions
BMI (kg/m2) 26.1 ± 3.2 27.5 ± 3.9 1.10 (1.04–1.16)
Family history of diabetes 20.5 28.8 1.94 (1.25–30.1)
Smoking 23.2 20.3 0.88 (0.54–1.42)
Cardiovascular symptoms
Chest pain 6.7 11.0 1.97 (1.04–3.75)
Pain during walking 4.0 7.6 2.30 (1.10–4.81)
Pain during walking with 2.9 3.4 1.10 (0.38–3.19)
need to slow down
Pain in calf during walking 2.4 2.5 1.06 (0.31–3.59)
Shortness of breath when
Washing/dressing 2.7 3.4 1.18 (0.40–3.49)
Walking with people of the same age 4.2 3.4 0.72 (0.25–2.08)
Not cycling 40.1 66.1 2.99 (1.97–4.55)
Level 3: additional measurements
Diastolic blood pressure (mmHg) 76.3 ± 10.7 76.8 ± 11.4 1.00 (0.98–1.03)
Systolic blood pressure (mmHg) 135.7 ± 19.7 143.6 ± 20.6 1.02 (1.00–1.03)
WHR 0.91 ± 0.09 0.94 ± 0.09 12.51 (1.04–150.8)
Data are means ± SD or %. Odds ratios (ORs) are adjusted for age and sex. Obesity is defined in this study
as BMI 30 kg/m2. Blood pre s s u re measurements exclude those subjects using antihypertensive medication.
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To compare the perf o rmance of the dif-
f e rent risk functions, re c e i v e r-operator char-
acteristic (ROC) curves were constru c t e d .
ROC curves characterize the re l a t i o n s h i p
between sensitivity and 1 – specific i t y. The
sensitivity of a test is the pro b a b i l i t y
(0–100%) that the test is positive for sub-
jects with diabetes. The specificity is the
p robability that a test is negative for subjects
without diabetes. The area under the ROC
c u rve quantifies how well the test corre c t l y
distinguishes a subject with diabetes from a
subject without diabetes; the larger the are a
under the curve, the better the perf o rm a n c e
of the risk function. The Epistat package
was used to construct the ROC curves and
their 95% CIs.
At diff e rent cutoff points of the pre d i c-
tive models, the number of subjects who
would need to be re f e rred for further test-
ing to diagnose diabetes was calculated, as
was the number of subjects with undiag-
nosed diabetes who would be missed. To
be able to compare the perf o rmance of the
t h ree predictive models with pre v i o u s l y
re p o rted studies (10–12), we used cutoff
values yielding a specificity of 55%.
R E S U LT S
Selection of the predictive models
C o m p a red with the nondiabetic subjects,
the group of individuals with newly
detected diabetes (n = 118) were more
likely to be men and to have a higher BMI,
WHR, and systolic blood pre s s u re, to use
m o re antihypertensive medication, and to
have a family history of diabetes (Table 1).
Chest pain was more prevalent among sub-
jects with newly detected diabetes, as was
pain during walking. Tw o - t h i rds of the sub-
jects with newly detected diabetes re p o rt e d
that they did not bicycle, compared with
40% of the nondiabetic subjects.
In the first predictive model (PM1) age,
sex, presence of obesity, and use of antihy-
p e rtensive medication were selected (Ta b l e
2). The second predictive model (PM2)
also included family history of diabetes,
BMI (continuous), and physical activity
(operationalized as cycling). The variables
obtained from physical examination (blood
p re s s u re and WHR) did not have an addi-
tive predictive value, resulting in a third
p redictive model (PM3) that was identical
to the second one. The re g ression coeff i-
cients were transformed into scores. The
age score showed that from age 55 onward ,
e v e ry increment of 5 years corre s p o n d e d
with an additional score of 2 points for
PM1 and 1 point for PM2. The aggre g a t e d
s c o re ranged from 0 to a maximum of 22
for PM1 and from 19 to 60 for PM2.
Validation of the predictive models
Both predictive models were evaluated in
the Hoorn Study. In this study, 110 of
2,364 subjects had newly detected dia-
betes. The characteristics of the Hoorn
population diff e red slightly from those of
subjects studied in the Rotterdam Diabetes
S t u d y. The mean age of subjects with or
without newly detected diabetes was lower
(66.2 and 60.5 years). The pro p o rtion of
women among the two groups was 47%.
Table 2—Results of stepwise logistic regression analyses predicting newly detected diabetes: the content of two predictive models (Rotterdam
Diabetes Study)
PM1 PM2
Variables Unit LRC Score OR (95% CI) P value LRC Score OR (95% CI) P value
Constant 3.02 5.42
Age Per 5-year increment 0.19 2 1.21 (1.02–1.44) 0.03 0.13 1 1.13 (0.95–1.36) 0.17
from 55 years
Sex 0, female; 1, male 0.46 5 1.59 (1.07–2.36) 0.02 0.66 7 1.94 (1.28–2.93) 0.02
Use of antihypertensive 0, no; 1, yes 0.42 4 1.53 (1.00–2.32) 0.04 0.27 3 1.31 (0.85–2.03) 0.22
medication
Presence of obesity 0, not obese; 1, obese 0.51 5 1.68 (1.02–2.76) 0.05
Physical inactivity 0, cycling; 1, not cycling 1.04 10 2.83 (1.85–4.33) 0.001
Family history of diabetes 0, no; 1, yes 0.70 7 2.01 (1.28–3.18) 0.003
BMI Continuous 0.07 1 1.07 (1.02–1.13) 0.01
Scores were obtained by multiplying the regression coefficient by 10 and rounding to the nearest integer. Obesity is defined as BMI 30 kg/m2 for both sexes. The
actual BMI of a subject has to be multiplied by 1 and added to the total sum of scores. LCR, logistic regression coefficient; OR, odds ratio.
Table 3—Percentage of newly detected diabetes in both studies according to strata of the aggregated score of the two predictive models
PM1 PM2
Prevalence Prevalence
Score Rotterdam Diabetes Study Hoorn Study Score Rotterdam Diabetes study Hoorn Study
4 18/227 (8.6) 10/606 (1.7) 33 10/239 (4.4) 14/869 (1.6)
4–6 22/268 (8.9) 27/803 (3.5) 33–36 17/188 (9.9) 20/497 (4.1)
7–8 23/180 (12.7) 9/269 (3.5) 37–41 16/175 (10.1) 21/458 (5.0)
9–10 24/140 (20.7) 20/336 (6.4) 42–47 30/216 (16.1) 20/343 (6.2)
11 31/174 (20.9) 44/350 (14.4) 48 45/171 (35.7) 34/197 (21.0)
Total 118/989 (13.5) 110/2364 (4.9) Total 118/989 (13.5) 110/2364 (4.9)
Data are number of subjects with newly detected diabetes/total n (%).
The pro p o rtion of subjects with obesity
among newly diagnosed diabetic and non-
diabetic subjects was higher compared with
the Rotterdam Diabetes Study (36.4 and
14.0, respectively). The pro p o rtion of sub-
jects using antihypertensive drugs was
lower in the Hoorn Study (28.7 [newly
detected diabetes] and 13.3% [nondia-
betic]), as was the percentage of subjects
re p o rting that they did not cycle (41.3 and
2 3 . 6 % ) .
In Table 3, the percentage of newly
detected diabetes in the Rotterdam Dia-
betes Study and in the Hoorn Study is
given according to strata of the aggre g a t e d
s c o re of the two predictive models. The
p e rcentage of newly detected diabetes
i n c reased with a higher score in both mod-
els. In the Rotterdam Study, 20% of the
subjects with a score 9 in PM1 and 4 2
in PM2 had newly detected diabetes. In the
H o o rn study, the optimal cutoff point was
11 in PM1 and 48 in PM2.
The area under the ROC curve was
l a rger for PM2 (0.74 [95% CI 0.70–0.78])
c o m p a red with PM1 (0.68 [0.64–0.72]),
but the confidence intervals overlap (Fig.
1). Of the 110 subjects (63.6%) with newly
detected diabetes, 70 had positive scores on
both PM1 and PM2 when using the cutoff
point of 6 for PM1 and 36 for PM2.
With a specificity of 55%, the positive
p redictive value (PPV) of PM1 was 8%, and
that of PM2 was 7.2%. When characteriz-
ing the false-positive subjects, 14.4% had
IGT in PM1 and 13.9% in PM2 (Table 4).
The predictive models select subjects
who should undergo further testing for
diagnosing diabetes. In Fig. 2, the number
of subjects re q u i red to undergo blood glu-
cose testing (e.g., an OGTT) to find one
diabetic subject is plotted against the dif-
f e rent cutoff points of the predictive mod-
els. When no predictive model is used to
select subjects with a higher risk of undi-
agnosed diabetes, 20.5 subjects would have
to undergo an OGTT to find one diabetic
subject (assuming a prevalence of undiag-
nosed diabetes of 5%, as in the Hoorn
Study). At higher cutoff points, fewer sub-
jects have to be re f e rred for further testing.
H o w e v e r, the percentage of diabetic sub-
jects missed will increase (Fig. 3).
C O N C L U S I O N S — We developed
t h ree predictive models for selecting sub-
jects with an increased risk of having undi-
agnosed diabetes. In the first pre d i c t i v e
model (PM1), we included only inform a-
tion readily available to the general practi-
t i o n e r. The variables age, sex, use of
a n t i h y p e rtensive medication, and pre s e n c e
of obesity appeared to be predictive. In the
second predictive model (PM2), items that
could easily be obtained by simple addi-
tional questions were included. A family
h i s t o ry of diabetes and physical inactivity
(in this Dutch study operationalized as
bicycling) were included as risk factors in
this model, of which the variables of the
first model were also part. The third pre-
dictive model (PM3) was rejected, since
the items obtainable by noninvasive meas-
u rements (blood pre s s u re or WHR) had no
additive predictive value in this study pop-
ulation, resulting in a PM3 similar to PM2.
To gain more insight into the perf o rm a n c e
of the two predictive models, both were
evaluated in another study population. The
d i ff e rences between the two models were
rather small.
In the Rotterdam Study, 20% of the
subjects with a score 9 in PM1 and 4 2
in PM2 had newly detected diabetes. In the
H o o rn study, the optimal cutoff point was
11 in PM1 and 48 in PM2. This is pro b-
ably due to the fact that the diff e rences in
characteristics between newly diagnosed
diabetic subjects and the nondiabetic sub-
jects are larger in the Hoorn Study com-
p a red with the Rotterdam study. For
example, the mean age in the Rotterd a m
study is 66.2 years for nondiabetic subjects
and 67.8 years for diabetic subjects, where a s
in the Hoorn study, the mean ages are 60.2
and 66.5 years, re s p e c t i v e l y.
In the first predictive model, obesity
was defined as BMI 30 kg/m2, whereas in
the second predictive model BMI was
included as a continuous variable. Assum-
ing that in reality a general practitioner can-
not exactly estimate whether a person has a
BMI below or above 30 kg/m2, the pre d i c-
tive value of this variable will be lower in
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Figure 1—ROC curves for PM1 and PM2 (Hoorn Study).
Table 4—Performance of PM1 and PM2 (Hoorn Study)
PM1 PM2
Cutoff point Score 6 Score 36




Negative predictive value 98 98
Characteristics of the false positives
% of subjects with IGT (n) 14.7 (130 of 882) 14.4 (133 of 923)
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clinical practice. The perf o rmance of PM1 is
thus slightly overestimated. However, the
BMI used in PM2 will usually be based on
s e l f - re p o rted height and weight instead of
taking these measurements, as was the case
in this study. It has been shown that self-
re p o rted height and weight lead to an
u n d e restimation of the BMI (18,19), and
this underestimation tends to be higher in
m o re obese subjects than in lean ones (20).
It is not clear whether this will influence the
p redictive value of PM2, but the perf o r-
mance of PM2 is likely to be slightly over-
estimated. When using the categorical
variable obesity instead of the continuous
variable in the PM2, the perf o rmance of this
model did not change (data not shown).
Physical activity was a highly discrimi-
native variable between subjects with and
without diabetes, an observation also
re p o rted in other studies (9,11). As has been
shown in a previous study (14), cycling was
the variable that contributes most to the
discrimination in the Netherlands. We have
chosen to use cycling as a variable in the
PM2, since now the subject only has to
answer one simple question, whereas when
using the more broad and vague variable
“physical activity,” a number of questions
have to be answered to arrive at a score .
O b v i o u s l y, in other countries, diff e rent activ-
ities will contribute to total activity.
Considering the small diff e re n c e s
between the two predictive models in per-
f o rmance, and the simplicity of the fir s t
one, PM1 seems to be the most appro p r i a t e
p redictive model to use in the curre n t
health care setting. The variables selected
for PM1 are very logical from a clinical
point of view and, since most general prac-
tices are computerized, it will be easy to
identify the subjects with a positive score
on PM1 by the computer.
Several other tools for screening undi-
agnosed diabetes have been developed in
earlier studies. The ADA suggests that
e v e ryone with more than one risk factor for
diabetes (family history of diabetes, obesity,
an at risk race, hypertension, signific a n t
hyperlipidemia, or a history of gestational
diabetes or delivery of heavy babies) should
be re f e rred to the general practitioner and
tested for diabetes (9). Herman et al. (11)
developed a classification tree in which age,
physical inactivity, family history of dia-
betes, and having given birth to a heavy
baby were predictive variables. In the
H o o rn Study (12), a questionnaire was
developed that included age, sex, obesity,
physical inactivity, frequent thirst, and some
F i g u re 2—E ffect of selecting subjects with a high risk of having undiagnosed diabetes, expressed as the
number of subjects that has to be referred for further testing to diagnose one diabetic subject.
Figure 3—The percentage of undiagnosed diabetic subjects that will be missed when using PM1 or
PM2.
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c a rdiovascular symptoms. The question-
n a i res differ in the number of risk factors,
but all include age, sex, and family history
of diabetes. In our study, no obstetrical
questions were asked, and thus the variable
“ d e l i v e ry of heavy babies” could not be
included in the analysis.
The perf o rmance of the re p o rted tools
has been compared by Ruige et al. (12) in
yet another Dutch population-based study
with a prevalence of newly detected dia-
betes similar to that of the Hoorn Study.
PPVs ranged from 5 to 7%, which is com-
parable to the PPVs of our PM1 (8%) and
PM2 (7.2%). The choice of the cutoff values
e n s u red that the specificity was 55% for
all tools to facilitate a comparison between
the PPVs. These low PPVs place into ques-
tion the usefulness of a tool for selection of
subjects with high risk for undiagnosed dia-
betes. On the one hand, they are simple and
easy to use. Without much eff o rt, the pop-
ulation to be tested for diabetes (using a
blood glucose measurement) can be
reduced. They are, more o v e r, useful in
making the general practitioner and the
patients more attentive to the problem of
undiagnosed diabetes. For example, the
possibility of having undiagnosed diabetes
seems to be underestimated in men, con-
sidering the high score of this variable in
both predictive models (score = 5 in PM1
and 7 in PM2). After selection of a high-risk
g roup, a large number of people will
nonetheless turn out not to have diabetes,
depending on the cutoff point used. In
addition, a number of subjects with undi-
agnosed diabetes will be missed, since they
will have a score below the cutoff point.
In the development and evaluation of
the questionnaires, attention has only been
paid to screening of undiagnosed diabetes.
H o w e v e r, there will also be a number of
subjects with IGT. In the Hoorn Study,
15% of the subjects who scored positively
on the first predictive model had IGT, using
a cutoff point of 6. These subjects have
been shown to have an increased risk for
developing diabetes (21), as well as an
i n c reased risk for (macrovascular) compli-
cations (22–24). Intervention strategies in
people with IGT or other high-risk charac-
teristics may prevent or delay type 2 dia-
betes (25,26). More insight into this
question will be obtained from the Diabetes
P r i m a ry Prevention Trial, in which tre a t-
ment of people with high-risk characteris-
tics such as IGT will be tested (27).
To conclude, the predictive models can
be used to identify subjects with a higher
risk for having undiagnosed diabetes. Both
of the predictive models we developed may
easily be used in the current health care set-
ting. However, from a pragmatic point of
v i e w, PM1 seems to be the most appro p r i-
ate predictive model. Until the discussion is
solved about who, when, and how to
s c reen for undiagnosed diabetes on a com-
munity-wide basis, general practitioners
can use PM1 to determine which of their
patients have a higher probability of having
undiagnosed diabetes.
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